Emerson Electric Company (EMR) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed EMR price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$143.07
Today
Analyst consensus
$156.47
+9.37% · 12M
2030 Base
—
— future
NPV today
—
@ — WACC
32 analysts:
7 Buy9 Hold2 Sell
Management guidance
Emerson has provided FY2026 revenue guidance of $19.14B (6.26% growth from FY2025's $18.02B). Management highlighted strong order momentum (+9% YoY in Q1 FY2026) and expects earnings growth to accelerate from low-single-digits in H1 to low-double-digits by year-end FY2026. CEO outlined plans to return $10B to shareholders through buybacks and dividends, signaling confidence in cash generation.
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
2030E driver
Bear
Base
Bull
Revenue
$24.1B
$24.1B
$24.1B
P/S multiple
1.0x
2.0x
4.0x
Diluted shares
0M
0M
0M
Net debt
—
—
—
Implied P/E †
—
—
—
2030 Price
$—
$—
$—
NPV @ —
$—
$—
$—
† Implied P/E: Multiples remain elevated across all three scenarios because EMR is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $— base case
EMR catalysts and risks
Growth catalysts
+ AI infrastructure demand and digital automation adoption driving orders +9% YoY
+ $2B Louisiana Green Fuels automation contract win (first-of-its-kind carbon-neutral power plant with CCS)
+ Nearshoring and energy security trends favoring North American manufacturing automation
+ AspenTech acquisition integration and software-as-a-service recurring revenue expansion
+ Strong backlog conversion in H2 FY2026 and into FY2027
Key risks
- China market weakness and European softness offsetting North American strength
- Tariff and foreign exchange headwinds impacting margins
- AspenTech execution risk and software integration challenges
- Valuation concerns (P/E 32.4x vs historical averages, Simply Wall St DCF fair value $93.06)
- Slowdown in industrial capex if economic growth decelerates
Methodology · Emerson Electric Company 2030 stock forecast model
Emerson Electric Company 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 32 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
1. Share dilution
Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (-100% cumulative for EMR by 2030)
2. Net debt
EV minus net debt yields equity value; debt projected from capex cycle trajectory (— by 2030)
3. Time value
NPV calculated using — WACC (sector fallback)
4. Multiple framework
P/S compresses with scale: bear 1.0x / base 2.0x / bull 4.0x
5. Scenario design
Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.
EMR price target FAQ
How is the Emerson Electric Company 2030 stock forecast calculated?
The EMR 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
What is the analyst consensus on EMR stock?
32 analysts cover EMR with an average 12-month price target of $156.47. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.
